Chen, Dandan

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Schwartz, G. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., Jukema, J. W., Landmesser, U., López-Jaramillo, P., Manvelian, G., Pordy, R., et al. (2021) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 150

Machine Learning-Based Prediction for 4-Year Risk of Metabolic Syndrome in Adults: A Retrospective Cohort Study

Zhang, H., Chen, D., Shao, J., Zou, P., Cui, N., Tang, L., Wang, X., Wang, D., Wu, J., & Ye, Z. (2021) · Risk Management and Healthcare Policy

Artificial Intelligence in HealthcareMachine Learning in Healthcare

Cited by 16

Green sanctuaries: residential green and garden space and the natural environment mitigate mental disorders risk of diabetic patients

Xue, E., Zhao, J., Ye, J., Wu, J., Chen, D., Shao, J., Li, X., & Ye, Z. (2025) · BMC Medicine

Urban Green Space and HealthHealth disparities and outcomes

Cited by 3